[go: up one dir, main page]

WO1987004430A3 - Benzazepines fondues - Google Patents

Benzazepines fondues Download PDF

Info

Publication number
WO1987004430A3
WO1987004430A3 PCT/US1987/000042 US8700042W WO8704430A3 WO 1987004430 A3 WO1987004430 A3 WO 1987004430A3 US 8700042 W US8700042 W US 8700042W WO 8704430 A3 WO8704430 A3 WO 8704430A3
Authority
WO
WIPO (PCT)
Prior art keywords
fused benzazepines
useful
benzazepines
fused
hypertension
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/US1987/000042
Other languages
English (en)
Other versions
WO1987004430A2 (fr
Inventor
Joel Gilbert Berger
Wei Kong Chang
Elijah Herman Gold
John Welch Clader
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck Sharp and Dohme LLC
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Priority to JP62500944A priority Critical patent/JPH0681745B2/ja
Priority to KR1019870700836A priority patent/KR900007781B1/ko
Priority to AT87900939T priority patent/ATE54911T1/de
Priority to DE8787900939T priority patent/DE3763928D1/de
Priority to HU87914A priority patent/HU199805B/hu
Publication of WO1987004430A2 publication Critical patent/WO1987004430A2/fr
Priority to DK479087A priority patent/DK164161C/da
Priority to FI874006A priority patent/FI83512C/fi
Priority to NO873874A priority patent/NO172046C/no
Publication of WO1987004430A3 publication Critical patent/WO1987004430A3/fr
Anticipated expiration legal-status Critical
Priority to NO88883602A priority patent/NO172047C/no
Priority to KR909072051A priority patent/KR920000272B1/ko
Priority to SG1286/92A priority patent/SG128692G/en
Priority to HK29493A priority patent/HK29493A/en
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
    • C07D223/14—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Cardiology (AREA)
  • Pain & Pain Management (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

Abstract

Certaines benzazépines fondues sont utiles dans le traitement des psychoses, de la dépression, de la douleur et de l'hypertension. Les composés peuvent également être utiles comme vasodilatateurs rénaux. Sont décrits des compositions pharmaceutiques, des procédés de préparation et de nouvelles compositions intermédiaires.
PCT/US1987/000042 1986-01-16 1987-01-14 Benzazepines fondues Ceased WO1987004430A2 (fr)

Priority Applications (12)

Application Number Priority Date Filing Date Title
JP62500944A JPH0681745B2 (ja) 1986-01-16 1987-01-14 縮合ベンゾアゼピン
KR1019870700836A KR900007781B1 (ko) 1986-01-16 1987-01-14 융합된 벤즈아제핀
AT87900939T ATE54911T1 (de) 1986-01-16 1987-01-14 Kondensierte benzazepine.
DE8787900939T DE3763928D1 (de) 1986-01-16 1987-01-14 Kondensierte benzazepine.
HU87914A HU199805B (en) 1986-01-16 1987-01-14 Process for producing condensed benzazepine derivatives and pharmaceutical compositions comprising such compounds
DK479087A DK164161C (da) 1986-01-16 1987-09-14 Kondenserede benzazepiner, fremgangsmaade til fremstilling deraf, farmaceutiske praeparater indeholdende forbindelserne, fremgangsmaade til fremstilling af saadanne praeparater samt anvendelse af forbindelserne til fremstilling af farmaceutiske praeparater
NO873874A NO172046C (no) 1986-01-16 1987-09-15 Analogifremgangsmaate for fremstilling av terapeutisk aktive, kondenserte benzazepiner
FI874006A FI83512C (fi) 1986-01-16 1987-09-15 Foerfarande foer framstaellning av farmakologiskt vaerdefulla fusionerade bensazepinfoereningar.
NO88883602A NO172047C (no) 1986-01-16 1988-08-12 Benzo(d)azepinderivater
KR909072051A KR920000272B1 (en) 1986-01-16 1990-09-15 Fused benzazepines
SG1286/92A SG128692G (en) 1986-01-16 1992-12-17 Fused benzazepines
HK29493A HK29493A (en) 1986-01-16 1993-03-25 Fused benzazepines

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US82047186A 1986-01-16 1986-01-16
US820,471 1997-03-17

Publications (2)

Publication Number Publication Date
WO1987004430A2 WO1987004430A2 (fr) 1987-07-30
WO1987004430A3 true WO1987004430A3 (fr) 1988-03-24

Family

ID=25230864

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US1987/000042 Ceased WO1987004430A2 (fr) 1986-01-16 1987-01-14 Benzazepines fondues

Country Status (19)

Country Link
EP (2) EP0254737B1 (fr)
JP (1) JPH0681745B2 (fr)
KR (1) KR900007781B1 (fr)
AU (1) AU588080B2 (fr)
CA (1) CA1333485C (fr)
CS (1) CS414091A3 (fr)
DK (1) DK164161C (fr)
ES (1) ES2031834T3 (fr)
FI (1) FI83512C (fr)
GR (1) GR3000994T3 (fr)
HU (1) HU199805B (fr)
IE (1) IE59651B1 (fr)
IL (2) IL81268A0 (fr)
NZ (1) NZ218953A (fr)
OA (1) OA08660A (fr)
PT (1) PT84109B (fr)
SG (1) SG128692G (fr)
WO (1) WO1987004430A2 (fr)
ZA (1) ZA87291B (fr)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4973586A (en) 1986-01-16 1990-11-27 Schering Corporation Fused benzazepines, compositions of, and medical use thereof
EP0363353B1 (fr) * 1987-07-15 1992-07-22 Schering Corporation Benzazepines fusionnees
DK325188D0 (da) * 1988-06-15 1988-06-15 Novo Industri As Hidtil ukendte benzazepinderivater
WO1990001476A1 (fr) * 1988-07-29 1990-02-22 Schering Corporation PROCEDE DE SYNTHESE ENANTIOSPECIFIQUE D'INTERMEDIAIRES POUR HEXAHYDRO-BENZO[d]NAPHTHO[2,1-b]AZEPINES
US5091526A (en) * 1988-07-29 1992-02-25 Schering Corporation Process for the enantiospecific synthesis of intermediates for hexahydro-benzo[d]-naphtho[2,1-b]azepines
US5104814A (en) * 1988-11-22 1992-04-14 Schering Corporation Assay kit and methods for neuroleptic drugs
FR2642065B1 (fr) * 1989-01-24 1991-05-24 Lipha Derives d'acides benzocycloalcenyl dihydroxy alcanoiques, procede de preparation et medicaments les contenant
FI923458A7 (fi) * 1990-02-02 1992-07-31 Schering Corp 4,5-sykloalkano-3-bentsatsepin-7-olijohdannaiset ja niiden käyttö
US5463051A (en) * 1993-09-27 1995-10-31 Schering Corporation Process for preparing benzazepine intermediates for the synthesis of D1 antagonists
US5461148A (en) * 1993-09-27 1995-10-24 Schering Corporation Process for preparing benzazepine intermediates for the synthesis of D1 antagonists
US5461147A (en) * 1993-09-27 1995-10-24 Schering Corporation Process for preparing benzazepine intermediates for the synthesis of D1 antagonists
AR027687A1 (es) 2000-03-22 2003-04-09 Yakult Honsha Kk Procedimiento para preparar camptotecina
EP1490090A4 (fr) 2002-02-22 2006-09-20 New River Pharmaceuticals Inc Systemes de distribution d'agents actifs et methodes de protection et d'administration d'agents actifs
CA2495879C (fr) 2002-08-29 2011-04-26 Schering Corporation Antagonistes selectifs du recepteur d1/d5 pour le traitement de l'obesite et de troubles snc
CA2526017A1 (fr) * 2003-05-22 2005-04-21 Schering Corporation Antagonistes selectifs des recepteurs d<sb>1</sb>/d<sb>5</sb> utilises dans le traitement de l'obesite et des troubles du systeme nerveux central
US8586634B2 (en) 2007-06-15 2013-11-19 University Of Florida Research Foundation, Inc. Therapeutic compounds

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3393192A (en) * 1965-04-26 1968-07-16 Schering Corp Novel benzazepines
GB1221324A (en) * 1967-02-17 1971-02-03 Geigy Ag J R New processes for the production of benzazepine derivatives
FR2137626A1 (en) * 1971-05-10 1972-12-29 Hoffmann La Roche 6-(benzazepine-6-yl) benzoic acid salts-intermediates for - rheadan alkaloids
US3939165A (en) * 1974-11-14 1976-02-17 Morton-Norwich Products, Inc. 5,6,6A,6B,7,8-Hexahydrobenz[a]phenanthridine hydrochloride

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1118688A (en) 1967-02-17 1968-07-03 Scherico Ltd Novel benzazepines and process for making same
US3609138A (en) 1967-12-22 1971-09-28 Ciba Geigy Corp 1-aryl-3-benzazepines
US4011319A (en) 1975-07-02 1977-03-08 Smithkline Corporation Pharmaceutical compositions and methods involving benzazepine derivatives
US4284555A (en) 1979-04-27 1981-08-18 Schering Corporation 7-Chloro-8(substituted amino carbonyloxy)-1-phenyl-2,3,4,5-tetrahydro-1H-3-benzazepines
US4477378A (en) 1980-02-05 1984-10-16 Schering Corp. Esters of substituted 8-hydroxy-1-phenyl-2,3,4,5-tetrahydro-1H-3-benzazepines

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3393192A (en) * 1965-04-26 1968-07-16 Schering Corp Novel benzazepines
GB1221324A (en) * 1967-02-17 1971-02-03 Geigy Ag J R New processes for the production of benzazepine derivatives
FR2137626A1 (en) * 1971-05-10 1972-12-29 Hoffmann La Roche 6-(benzazepine-6-yl) benzoic acid salts-intermediates for - rheadan alkaloids
US3939165A (en) * 1974-11-14 1976-02-17 Morton-Norwich Products, Inc. 5,6,6A,6B,7,8-Hexahydrobenz[a]phenanthridine hydrochloride

Also Published As

Publication number Publication date
FI874006L (fi) 1987-09-15
EP0254737B1 (fr) 1990-07-25
FI83512B (fi) 1991-04-15
EP0230270B1 (fr) 1990-08-01
CA1333485C (fr) 1994-12-13
EP0254737A1 (fr) 1988-02-03
WO1987004430A2 (fr) 1987-07-30
PT84109A (en) 1987-02-01
GR3000994T3 (en) 1991-12-10
HU199805B (en) 1990-03-28
DK479087A (da) 1987-09-14
DK164161B (da) 1992-05-18
IE59651B1 (en) 1994-03-09
FI874006A0 (fi) 1987-09-15
AU6892087A (en) 1987-08-14
AU588080B2 (en) 1989-09-07
ES2031834T3 (es) 1993-01-01
SG128692G (en) 1993-03-12
EP0230270A3 (en) 1987-10-21
IE870112L (en) 1987-07-16
IL103007A (en) 1993-07-08
HUT48600A (en) 1989-06-28
IL81268A0 (en) 1987-08-31
PT84109B (pt) 1989-07-31
KR900007781B1 (ko) 1990-10-20
NZ218953A (en) 1990-03-27
EP0230270A2 (fr) 1987-07-29
JPH0681745B2 (ja) 1994-10-19
DK479087D0 (da) 1987-09-14
KR880700794A (ko) 1988-04-12
ZA87291B (en) 1987-11-25
OA08660A (en) 1988-11-30
JPS63502348A (ja) 1988-09-08
CS414091A3 (en) 1992-05-13
DK164161C (da) 1992-10-26
FI83512C (fi) 1991-07-25

Similar Documents

Publication Publication Date Title
WO1987004430A3 (fr) Benzazepines fondues
GB2200109B (en) New pharmacologically active compounds, methods for the preparation thereof and compositions containing the same
AU585561B2 (en) New peptide-aldehydes, process for the preparation thereof and pharmaceutical compositions containing the same
AU7890487A (en) Impact resistant polymeric compositions and process for the preparation thereof
EP0244616A3 (en) Polybutyl and polyisobutyl amine, process for their preparation and fuel or lubricating compositions containing them
EP0336205A3 (en) Process for the preparation of isocyanuratepolyisocyanates, the compounds obtained according to this process and their use
AU6913687A (en) Solid antitartar mouth deodorant composition
EP0456062A3 (en) Process for preparation of isocyanuratepolyisocyanates, the compounds prepared according to this process, and their use
IL83760A (en) 3-pyrazoliomethyl-3- cephem-4-carboxylate derivatives, process for the preparation thereof, and pharmacetuical compositions containing the same
AU6813987A (en) Ocular antihypertensive composition for topical use
IL82231A0 (en) 1-hydroxy-2-pyridones,process for their preparation,and pharmaceutical compositions which contain them and intermediates formed in the preparation of the 1-hydroxy-2-pyridones
JPS6413070A (en) Novel compound, manufacture and medicinal composition
IE882594L (en) Water-hardening polymer preparation
AU7359787A (en) Modified asphalt compositions
OA08608A (en) Pestical compositions and process for preparation thereof.
DE3560169D1 (en) Alpha-(o-chlorophenyl)-aminomethylene-beta-formylamino-propionitrile, process for its preparation and its use in the preparation of 2-methyl-4-amino-5-formylaminomethyl pyrimidine
AU5116590A (en) N-containing heterocyclic compounds, processes for the preparation thereof and composition comprising the same
AU7329787A (en) Improved copolymers, precursors therefor, compositions containing said copolymers, and methods for their preparation
GR3006671T3 (fr)
AU7324087A (en) New immunosuppressant cyclodepsipeptides, process for their preparation and pharmaceutical compositions containing them
PL340381A1 (en) Novel 19-norsteroids substituted at position 11beta, method of obtaining them, intermediate compounds used in that method, their application as drugs and pharmacological compositions containing them
EP0253272A3 (en) Addition compounds, process for their preparation and their application
DE3572498D1 (en) 3-methylbutene-1 polymer composition, and process for its preparation
AU9139591A (en) Process for the preparation of bromonitro-alcohols, dibromonitro-alcohols and blends thereof
EP0381141A3 (fr) Dérivés d&#39;acides aryl- ou hétéroaryl-1-alkyl-pyrrole-2-carboxyliques utiles dans le traitement de maladies en relation avec l&#39;interleukine-1

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AU DK FI HU JP KR NO

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): AT BE CF CG CH CM DE FR GA GB IT LU ML MR NL SE SN TD TG

WWE Wipo information: entry into national phase

Ref document number: 1987900939

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 874006

Country of ref document: FI

WWP Wipo information: published in national office

Ref document number: 1987900939

Country of ref document: EP

AK Designated states

Kind code of ref document: A3

Designated state(s): AU DK FI HU JP KR NO

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): AT BE CF CG CH CM DE FR GA GB IT LU ML MR NL SE SN TD TG

WWG Wipo information: grant in national office

Ref document number: 1987900939

Country of ref document: EP

WWG Wipo information: grant in national office

Ref document number: 874006

Country of ref document: FI